Triple Crown OG buds
Category: Nugs | Posted on Wed, May, 8th 2013 by THCFinder
Colorado legislature gives final approval to historic marijuana bill
Category: Legalization | Posted on Wed, May, 8th 2013 by THCFinder
The Colorado legislature on Wednesday gave final approval to a bill asking voters to impose taxes on recreational marijuana, inching the state legislature closer to becoming the first in the country to pass laws regulating recreational pot.
The state Senate approved the tax measure and another one spelling out rules for marijuana stores and then sent both to the House on Wednesday morning. The House quickly passed House Bill 1318, the bill on marijuana taxes, and sent it to the governor. House members will now take up the second measure.
Sen. Mark Scheffel, R-Parker, said on the Senate floor there could be some "bounce back-and-forth" between the two chambers during the final day of the session.
The Senate's votes Wednesday morning came with little discussion. One day after lengthy debates on both bills, only Scheffel stood to speak about the bills on Wednesday.
Cannabis-based Medicine approved in Italy
Category: Medical Marijuana | Posted on Wed, May, 8th 2013 by THCFinder
Cambridge medical technology business, GW Pharmaceuticals, has earned a key European approval for its cannabis-based prescription medicine Sativex® in Italy – and a €250k windfall in the process.
Full marketing authorisation has been granted by the authorities in Italy for the treatment of moderate to severe spasticity in Multiple Sclerosis patients who have not responded adequately to other anti-spasticity medications.
Regulatory, pricing and reimbursement approvals are now in place for an expected commercial launch in September by GW’s partner, Almirall S.A. The breakthrough triggers a €250,000 milestone payment from Almirall to GW.
Justin Gover, CEO of GW, said: “The approval in Italy brings the total to 21 countries that have approved Sativex® for use in the treatment of MS spasticity.
“In granting reimbursement approval for Sativex®, we appreciate the foresight of the Italian authorities in recognising the value of a medicine that treats a particularly debilitating symptom of MS that is not adequately treated with currently available medications.
“We now look forward to working with our partners Almirall towards commercial launch in this important market in a few months’ time.”
- 172,746 Views Category: Odd
- 138,267 Views Category: Fun
- 128,480 Views Category: Culture
- 85,348 Views Category: Culture
- 84,159 Views Category: Fun
- 83,603 Views Category: Culture
- 67,157 Views Category: Culture
- 63,486 Views Category: Odd
- 56,462 Views Category: Fun
- 49,450 Views Category: Fun